Growth Metrics

QuidelOrtho (QDEL) Cash & Equivalents (2021 - 2026)

QuidelOrtho's Cash & Equivalents history spans 5 years, with the latest figure at $169.8 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 72.74% to $169.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $169.8 million, a 72.74% increase, with the full-year FY2025 number at $169.8 million, up 72.74% from a year prior.
  • Cash & Equivalents hit $169.8 million in Q4 2025 for QuidelOrtho, up from $98.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for QDEL hit a ceiling of $1.3 billion in Q2 2022 and a floor of $79.0 million in Q1 2024.
  • Historically, Cash & Equivalents has averaged $311.4 million across 5 years, with a median of $169.8 million in 2025.
  • Biggest five-year swings in Cash & Equivalents: crashed 77.74% in 2024 and later soared 72.74% in 2025.
  • Tracing QDEL's Cash & Equivalents over 5 years: stood at $578.4 million in 2021, then tumbled by 63.14% to $213.2 million in 2022, then plummeted by 43.95% to $119.5 million in 2023, then dropped by 17.74% to $98.3 million in 2024, then soared by 72.74% to $169.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for QDEL at $169.8 million in Q4 2025, $98.1 million in Q3 2025, and $151.7 million in Q2 2025.